171 related articles for article (PubMed ID: 10066841)
1. Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin.
Frey JL; Muro GJ; McDougall CG; Dean BL; Jahnke HK
Stroke; 1999 Mar; 30(3):489-94. PubMed ID: 10066841
[TBL] [Abstract][Full Text] [Related]
2. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
3. Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
Röttger C; Madlener K; Heil M; Gerriets T; Walberer M; Wessels T; Bachmann G; Kaps M; Stolz E
Stroke; 2005 Apr; 36(4):841-6. PubMed ID: 15731475
[TBL] [Abstract][Full Text] [Related]
4. Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke model.
Vanderschueren S; Van Vlaenderen I; Collen D
Stroke; 1997 Sep; 28(9):1783-8. PubMed ID: 9303026
[TBL] [Abstract][Full Text] [Related]
5. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.
del Zoppo GJ; Higashida RT; Furlan AJ; Pessin MS; Rowley HA; Gent M
Stroke; 1998 Jan; 29(1):4-11. PubMed ID: 9445320
[TBL] [Abstract][Full Text] [Related]
6. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis.
Wasay M; Bakshi R; Kojan S; Bobustuc G; Dubey N; Unwin DH
Stroke; 2001 Oct; 32(10):2310-7. PubMed ID: 11588319
[TBL] [Abstract][Full Text] [Related]
7. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.
Trouillas P; Nighoghossian N; Derex L; Adeleine P; Honnorat J; Neuschwander P; Riche G; Getenet JC; Li W; Froment JC; Turjman F; Malicier D; Fournier G; Gabry AL; Ledoux X; Berthezène Y; Ffrench P; Dechavanne M
Stroke; 1998 Dec; 29(12):2529-40. PubMed ID: 9836764
[TBL] [Abstract][Full Text] [Related]
8. Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial.
Coutinho JM; Ferro JM; Zuurbier SM; Mink MS; Canhão P; Crassard I; Majoie CB; Reekers JA; Houdart E; de Haan RJ; Bousser MG; Stam J
Int J Stroke; 2013 Feb; 8(2):135-40. PubMed ID: 22340437
[TBL] [Abstract][Full Text] [Related]
9. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
[TBL] [Abstract][Full Text] [Related]
10. Endovascular treatment of traumatic dural sinus thrombosis: case report.
Kuether TA; O'Neill O; Nesbit GM; Barnwell SL
Neurosurgery; 1998 May; 42(5):1163-6; discussion 1166-7. PubMed ID: 9588564
[TBL] [Abstract][Full Text] [Related]
11. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
12. Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review.
Viegas LD; Stolz E; Canhão P; Ferro JM
Cerebrovasc Dis; 2014; 37(1):43-50. PubMed ID: 24356180
[TBL] [Abstract][Full Text] [Related]
13. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis?
Bousser MG
Stroke; 1999 Mar; 30(3):481-3. PubMed ID: 10066839
[No Abstract] [Full Text] [Related]
14. Treatment of deep cerebral venous thrombosis by local infusion of tissue plasminogen activator.
Yamini B; Loch Macdonald R; Rosenblum J
Surg Neurol; 2001 Jun; 55(6):340-6. PubMed ID: 11483188
[TBL] [Abstract][Full Text] [Related]
15. [Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature].
Mele M; Mele A; La Torre PP; Cannone M
G Ital Cardiol (Rome); 2014 Apr; 15(4):240-3. PubMed ID: 24873813
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis.
Goldhaber SZ; Meyerovitz MF; Green D; Vogelzang RL; Citrin P; Heit J; Sobel M; Wheeler HB; Plante D; Kim H
Am J Med; 1990 Mar; 88(3):235-40. PubMed ID: 2106783
[TBL] [Abstract][Full Text] [Related]
17. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
[TBL] [Abstract][Full Text] [Related]
18. [Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns].
Álvarez Z P; Verdugo L P; Carvajal K L; Múhlhausen M G; Ríos A P; Rodríguez V D
Rev Chil Pediatr; 2015; 86(3):194-9. PubMed ID: 26235268
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
Vanderschueren S; Barrios L; Kerdsinchai P; Van den Heuvel P; Hermans L; Vrolix M; De Man F; Benit E; Muyldermans L; Collen D
Circulation; 1995 Oct; 92(8):2044-9. PubMed ID: 7554180
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological management of cerebral venous sinus thrombosis with full-dose IV heparin infusion and its clinical outcomes.
Fernandez A; Nair V; Mckeone A; Ho J
Am J Emerg Med; 2017 Aug; 35(8):1208.e1-1208.e3. PubMed ID: 28434771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
